Metastatic Cervical Cancer Recruiting Phase 3 Trials for Paclitaxel (DB01229)

Also known as: Metastatic Cervical Cancers / Cervical Cancer Metastatic

IndicationStatusPhase
DBCOND0036674 (Metastatic Cervical Cancer)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05446883QL1706 Plus Chemotherapy┬▒Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical CancerTreatment